As is quantified by qRT-PCR, 4 of these 7 recurrent patients without p53 mutation exhibited higher levels of PANDAR in platinum-resistant cancer tissues compared with their newly diagnosed periods (platinum-sensitive) (Fig. 6a). This evidence concerns the gene TP53 and cancer.